|
Catalogue
Number
|
Product
|
Order number / Unit
|
|
|
5020
|
DMEAN
|
5020.0010: 10 mg per vial
5020.0020: 20 mg per vial
Please inquire for customized
filling and bulk quantities.
|
|
|
Precursor for [18F]FDDNP
|
|
|
|
|
|
Due to patent related reasons we regret that we are not allowed to sell the product to the following countries: USA, Canada, Australia, Japan, Hongkong, and European Union.
|
|
|
Molar Mass: 291.35
|
|
|
C18H17N3O
|
|
|
[259739-01-0]
|
|
|
|
|
|
Reddish solid packaged in dark glass screw cap vials.
|
|
|
|
|
|
|
|
|
Purity: > 95 %
|
|
|
Certificates:
CoA; 1H and 13C NMR spectra
|
|
|
Chemical Name:
CA index name: Propanedinitrile, [1-[6-[methyl[2-[hydroxy]ethyl]amino]-2-naphthalenyl]ethylidene]-
|
|
|
Synonymes:
2-(1-{6-[(2-hydroxy)ethyl)(methyl)amino]-2-naphthyl}ethyliden)malonitrile; 2-(1,1-dicyanopropen-2-yl)-6-methyl-(2-hydroxoethyl)-amino)-naphthalene
|
|
|
Literature:
1. Barrio J. et al. Neurofibrillary tangles (NFTs) and beta-amyloid plaques (A-beta) demonstrated in vivo in Alzheimer′s disease (AD) patients. J. Cereb. Blood Flow Metab. 1999, 19, S2.
|
|
|
2. Adgeppa E.D. et al. Binding Characteristics of Radiofluorinated 6-Dialkylamino-2-Naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for beta-Amyloid plaques in Alzheimer′s Disease. J. Neurosci. 2001, 21, RC189.
|
|
|
|
|
|
|
|
|
|
|
|
date of product catalogue issue:
05 April 2012
|